Stocklytics Platform
APRE
Aprea Therapeutics
APRE46
$1.63arrow_drop_down1.80%-$0.03
Penny Stock
APRE
APRE46

$1.63

arrow_drop_down1.80%

Trendlines, Support and Resistance

lock

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Technical Indicators

NameValueActioninfoPnL (10y)Last upd.
RSI80.10Sell44.3%
MACD116.18Neutral275.7%
CCI150.41Sell150.3%
ADX56.36Neutral-
ATR71.61Buy-
WILLR-2.73Sell176.3%
ROC157.28Neutral402.7%
STOCHRSI50.58Neutral193.0%

Indicator Ratings

Hold

Buy
1
-87.50%
Hold
4
-50.00%
Sell
3
-62.50%
Ratings from: May
Total: 8
info

Balanced or Uncertain

This suggests that the technical indicators do not strongly favor either a buying or selling stance. In such cases, investors may need to rely on additional fundamental or market analysis to make a well-informed decision.

Aprea Therapeutics (APRE) Technical Analysis

Aprea Therapeutics Inc (APRE) is a biopharmaceutical company that focuses on the discovery and development of novel cancer therapeutics. The company's approach is based on a deep understanding of the biology of tumor suppressor protein p53, which is an important target for cancer treatment. Aprea Therapeutics' lead product candidate, APR-246, is a small molecule drug that reactivates mutant p53, restoring its transcriptional activity and triggering programmed cell death in cancer cells. The company has conducted multiple clinical trials to evaluate the safety and efficacy of APR-246 alone or in combination with other cancer therapies.
When analyzing the technical indicators for Aprea Therapeutics Inc (APRE) stock, several key factors can provide insights into the stock's current and future price movements. The relative strength index (RSI) is a momentum oscillator that measures the speed and change of price movements. An RSI above 70 indicates an overbought condition, while an RSI below 30 suggests an oversold condition. The average directional index (ADX) is used to determine the strength of a trend. A higher ADX value indicates a stronger trend, while a lower value suggests a weaker trend. The moving average convergence divergence (MACD) is a trend-following momentum indicator that shows the relationship between two moving averages of a security's price. A positive MACD value indicates bullish momentum, while a negative value suggests bearish momentum. The rate of change (ROC) is a momentum oscillator that measures the percentage change in price between the current price and the price a certain number of periods ago. A positive ROC suggests upward momentum, while a negative ROC indicates downward momentum. The stochastic relative strength index (STOCHRSI) is a combination of the RSI and stochastic oscillator. It measures the level of the RSI relative to its high-low range over a specified period of time. The Williams %R (WILLR) is a momentum indicator that identifies overbought or oversold conditions. A WILLR value below -80 indicates an oversold condition, while a value above -20 suggests an overbought condition.
add Aprea Therapeutics  to watchlist

Keep an eye on Aprea Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What are the technical signals for Aprea Therapeutics (APRE) stock based on the last 30 days?

The technical analysis for Aprea Therapeutics (APRE), using 8 key indicators (RSI, MACD, CCI, ADX, ATR, WILLR, ROC, STOCHRSI) over the last 30 days, reveals: 4 technical buy signals, including CCI, ATR, WILLR, and STOCHRSI. There are 0 technical sell indicators at this time. 4 technical hold signals, associated with RSI, MACD, ADX, and ROC. This analysis was last updated 2025 May 23.

Take Your Investments to a Whole New Level